Landscape Capital Management, L.L.C. Fibrogen Inc Transaction History

Landscape Capital Management, L.L.C.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$36.98 - $48.45 $600,592 - $786,876	-16,241 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$42.83 - $59.91 $522,012 - $730,183	-12,188 Reduced 42.87%	16,241 $883,000
Q4 2018 Feb 14, 2019	BUY	$37.97 - $60.16 $735,251 - $1.16 Million	19,364 Added 213.61%	28,429 $1.32 Million
Q3 2018 Nov 14, 2018	BUY	$56.3 - $67.25 $62,661 - $74,849	1,113 Added 14.0%	9,065 $551,000
Q2 2018 Aug 14, 2018	SELL	$44.9 - $64.95 $668,246 - $966,650	-14,883 Reduced 65.18%	7,952 $498,000
Q1 2018 May 11, 2018	SELL	$45.35 - $61.65 $172,647 - $234,701	-3,807 Reduced 14.29%	22,835 $1.06 Million
Q4 2017 Feb 13, 2018	BUY	$41.95 - $60.1 $1.12 Million - $1.6 Million	26,642 New	26,642 $1.26 Million
Q3 2017 Nov 14, 2017	SELL	$33.4 - $53.9 $770,905 - $1.24 Million	-23,081 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	23,081	23,081 $746,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.